NCT01119872

Brief Summary

Randomized controlled pilot trial in 70 patients with Acute Respiratory Distress Syndrome (ARDS) ventilated with low tidal volumes and limitation on airway pressure at 35 centimeters of water (cmH2O), to compare two different methods of selecting the level of Positive End-Expiratory Pressure (PEEP) to be applied: according to fraction of inspired oxygen (FiO2) needed or individualized according to the best compliance. Primary objective was evolution of arterial oxygenation during the 28 days. Secondary objectives were to measure its effects on hemodynamic parameters, 28-day mortality, number of ventilator-free days at day 28, Intensive Care Unit (ICU) and hospital stay, number of multiple-organ dysfunction-free days and a multivariate analysis of 28 day-mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2003

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 10, 2010

Completed
Last Updated

May 10, 2010

Status Verified

December 1, 2002

Enrollment Period

4.9 years

First QC Date

May 6, 2010

Last Update Submit

May 7, 2010

Conditions

Keywords

Positive-Pressure RespirationRespiration, Artificial

Outcome Measures

Primary Outcomes (1)

  • Arterial Oxygenation

    Evolution of arterial oxygenation during the 28 days after study randomization

    28 days

Secondary Outcomes (3)

  • Mortality

    28 days

  • Number of ventilator-free days at day 28

    28 days

  • multivariate analysis of mortality

    28 days

Study Arms (2)

Compliance-guided PEEP group

OTHER

Positive End-Expiratory Pressure(PEEP) level was set daily, according to the method described by Suter in 1978. Static compliance (Cst) was calculated at different levels of PEEP at a constant tidal ventilation of 6-8 ml/kg of predicted body weight. Cst was determined by dividing tidal volume by the difference between the pressure at the end of inflation hold and the PEEP. The maximum value of Cst in individual patients was considered as the best PEEP.

Other: Positive End-expiratory Pressure (PEEP)

FiO2-driven-PEEP group

OTHER

PEEP was set based on the patient fraction of inspired oxygen (FiO2) according to the Positive End-Expiratory Pressure(PEEP) strategy reported in 2000:"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network".

Other: Positive End-expiratory Pressure (PEEP)

Interventions

All patients were ventilated during 24 hours with low tidal volume (6-8 milliliters/kilogram of predicted body weight), plateau airway pressure limited at 35 centimeters of water, initial ventilator rate of 30 breaths/minute adjusted to maintain a pH goal of 7.30 to 7.45 to a maximum of 35 breaths/minute, fraction of inspired oxygen ensuring arterial oxygen saturation 88-95% or arterial partial pressure of oxygen of 55-80 mmHg. Level of Positive End-Expiratory Pressure (PEEP) applied according the 2 arms of treatment.

Also known as: Compliance-guided PEEP group: Grupo meseta, FiO2-driven-PEEP group: Grupo tabla
Compliance-guided PEEP groupFiO2-driven-PEEP group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Acute Respiratory Distress Syndrome (ARDS) according to the American-European Consensus Conference definition, after 24 hours under mechanical ventilation.

You may not qualify if:

  • Younger than 18-year-old
  • Pregnancy
  • Neuromuscular diseases
  • Intracranial hypertension. Head trauma
  • Left ventricular dysfunction
  • Mechanical ventilation for more than 72 hours
  • Previous barotrauma
  • Patients with terminal stage of an illness and high risk of mortality within 90 days
  • Patients who refused to consent to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Critical Care Unit. Universitary Hospital Principe de Asturias

Alcalá de Henares, Madrid, 28805, Spain

Location

Related Publications (3)

  • Acute Respiratory Distress Syndrome Network; Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8. doi: 10.1056/NEJM200005043421801.

    PMID: 10793162BACKGROUND
  • Suter PM, Fairley HB, Isenberg MD. Effect of tidal volume and positive end-expiratory pressure on compliance during mechanical ventilation. Chest. 1978 Feb;73(2):158-62. doi: 10.1378/chest.73.2.158.

    PMID: 340159BACKGROUND
  • Pintado MC, de Pablo R, Trascasa M, Milicua JM, Rogero S, Daguerre M, Cambronero JA, Arribas I, Sanchez-Garcia M. Individualized PEEP setting in subjects with ARDS: a randomized controlled pilot study. Respir Care. 2013 Sep;58(9):1416-23. doi: 10.4187/respcare.02068. Epub 2013 Jan 29.

MeSH Terms

Conditions

Respiratory Distress SyndromeRespiratory Aspiration

Interventions

Positive-Pressure Respiration

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • María del Consuelo Pintado, MD, PhD

    Critical Care Unit. Universitary Hospital Principe de Asturias

    PRINCIPAL INVESTIGATOR
  • Raúl de Pablo, MD, PhD

    Critical Care Unit. Universitary Hospital Principe de Asturias

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 6, 2010

First Posted

May 10, 2010

Study Start

January 1, 2003

Primary Completion

December 1, 2007

Study Completion

December 1, 2008

Last Updated

May 10, 2010

Record last verified: 2002-12

Locations